MEDICAL DEVICE NEWS MAGAZINE

Wednesday, September 28, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

Northwell Health Implements New Screening Technology – Evolv Express

Northwell Health has implemented new comprehensive detection systems that screen for weapons and contraband at the entrances of Long Island Jewish Medical Center in New Hyde Park, South Shore University Hospital in Bay Shore and Lenox Health Greenwich Village in Manhattan as part of an effort to bring the technology to all hospitals in the health system.

The seamless walk-through system, Evolv Express, from Massachusetts-based Evolv Technology, allows for a touchless experience while screening for weapons. The screening process, monitored at each location by Northwell’s security team, is immediate and designed to avoid bottlenecking and slow lines associated with older detection screening processes and technologies.

“The safety, security and well-being of our patients, visitors and team members are our top priorities,” said Michael Dowling, Northwell’s president and CEO. “To help ensure a safe environment for all who enter our facilities – and as part of Northwell’s broader safety and security efforts – we’re trying this next generation of screening devices.”

The high-tech systems, which will also be installed at other facilities in the health system, are part of a larger Northwell initiative to maintain the safety of employees, patients and visitors. The effort also includes more resources and trainings for team members to enhance workplace safety, said Scott Strauss, vice president of security and support systems.

Northwell has hosted hundreds of trainings over the last few years that include active-shooter drills, seminars on conflict de-escalation techniques and courses on how to respond to bleeding emergencies so that team members are better prepared in case of a crisis.

“Northwell is known for its world-class health care and it’s our mission to keep patients safe with world-class security measures,” said Strauss. “The installation of this new detection system is just the latest addition to a wide range of security protocols the health system has in place to protect those in our hospitals, minimize the risk of violence and maintain a safe working environment for our team members. This technology adds just another layer of safety – and improves confidence for everyone who enters these healing spaces.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Prodeon Medical Announces Randomization in the Expander-2 Pivotal Clinical Trial Evaluating the Company’s Investigational Treatment for Lower Urinary Tract Symptoms Associated to Benign Prostatic Hyperplasia

The first randomization was performed by Mark Sutton, M.D., F.A.C.S. at Houston Metro Urology in Houston, TX. Dr. Sutton specializes in comprehensive urologic services for men and women including BPH notes Prodeon Medical.

XRHealth Reports Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures

XRHealth notes the findings could lead to a discussion in the medical industry about using non-pharmaceutical interventions during surgical procedures that both enhance the patient experience during surgery and provide a better postoperative recovery.

New Study Suggests REN Comparable to Standard Care Prescribed Medications for Acute Treatment of Chronic Migraines

Prospective data from 78 adult patients with chronic migraines in the U.S. demonstrated effectiveness of REN across four parameters in comparison to standard-care medications.

By using this website you agree to accept Medical Device News Magazine Privacy Policy